Clinuvel Pharmaceuticals | CUV - Interest Expense On Debt

Stock Price
9.75
Daily Change
-0.08 -0.81%
Monthly
-11.52%
Yearly
-16.02%
Q1 Forecast
9.72

Clinuvel Pharmaceuticals reported AUD2.43M in Interest Expense on Debt for its fiscal semester ending in June of 2024.





Interest Expense On Debt Change Date
Avita Medical AUD 1.25M 100K Jun/2025
Medical Developments International AUD 18K 3K Jun/2025
Mesoblast USD 10.46M 260K Jun/2024
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Paradigm Biopharmaceuticals AUD 1000 3K Jun/2025
PYC Therapeutics AUD 17K 11K Jun/2025
Telix Pharmaceuticals AUD 7.62M 11.22M Dec/2025